The role of geroscience in understanding Alzheimer’s Disease

For more than 30 years, researchers have identified and quantified genetic and lifestyle factors for Alzheimer’s Disease (AD) and other dementias. Despite extensive research, the fundamental mechanisms behind these neurodegenerative diseases are still not fully understood, and effective management of AD is taking longer than expected.

Eckert & Ziegler Achieves European Approval for Theralugand® – Lutetium-177 Chloride (n.c.a) – Biotech Investments

EQS-News: Eckert & Ziegler SE / Key word(s): Regulatory Approval/Market Launch Eckert & Ziegler Achieves European Approval for Theralugand® – Lutetium-177 Chloride (n.c.a) 27.11.2024 /

November 28, 2024

Breakthrough recombinase technology ushers in precise, adaptable gene editing

A team of researchers at the Carl Gustav Carus Faculty of Medicine, TUD Dresden University of Technology, led by Prof. Frank Buchholz, has achieved a

February 2, 2024

Teladoc Health Joins Amazon’s Health Benefits Connector for Cardiometabolic Programs

What You Should Know: – Teladoc Health (NYSE: TDOC), a global leader in virtual care, announced a new collaboration with Amazon to improve access to

January 14, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.